Rothia mucilaginosa bacteremia, meningitis leading to diffuse cerebritis in an adolescent patient undergoing acute myeloid leukemia chemotherapy causing significant morbidity

Rachel Dena Robertson; Arun Panigrahi; Ritu Cheema

doi:10.1177/2050313X211063745

Rothia mucilaginosa bacteremia, meningitis leading to diffuse cerebritis in an adolescent patient undergoing acute myeloid leukemia chemotherapy causing significant morbidity

SAGE Open Med Case Rep. 2021 Dec 8:9:2050313X211063745. doi: 10.1177/2050313X211063745. eCollection 2021.

Authors

Rachel Dena Robertson¹, Arun Panigrahi², Ritu Cheema³

Affiliations

¹ Department of Pediatrics, UC Davis Children's Hospital, Sacramento, CA, USA.
² Division of Pediatric Hematology-Oncology, Department of Pediatrics, UC Davis Children's Hospital, Sacramento, CA, USA.
³ Division of Pediatric Infectious Disease, Department of Pediatrics, UC Davis Children's Hospital, Sacramento, CA, USA.

Abstract

Infections with Rothia mucilaginosa are rare. We present an unusual case of Rothia mucilaginosa in an immunocompromised host, which is usually considered a low virulence pathogen. The objective of this report is to highlight spectrum of clinical presentations in an immunocompromised individual and discuss various antimicrobial treatment options in the light of lack of definitive treatment guidelines for this organism.

Keywords: Rothia mucilaginosa; cerebritis; chemotherapy; immunocompromised; lung nodules; meningitis; septic emboli.

Publication types

Case Reports